Repository logo
  • English
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Research Outputs
  • Projects
  • People
  • Statistics
  • English
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Scholalry Output
  3. Publications
  4. Exploring immunotherapy with antibody-drug conjugates in solid tumor oncology
 
  • Details
Options

Exploring immunotherapy with antibody-drug conjugates in solid tumor oncology

Journal
Advances in Protein Chemistry and Structural Biology
ISSN
18761623
Date Issued
2024
Author(s)
Takhellambam Malemnganba
Anurag Kumar Pandey
Mishra, Amit Kumar 
Department of Bioscience and Bioengineering 
Sanjana Mehrotra
Vijay Kumar Prajapati
DOI
10.1016/bs.apcsb.2024.10.016
Abstract
Immunotherapy has emerged as a hallmark of hope in the formidable battle against solid tumors such as breast cancer, colorectal cancer, etc., with antibody-drug conjugates (ADCs) starting a new era of precision medicine. This chapter delves into the dynamic landscape of immunotherapeutic strategies, focusing on the transformative potential of ADCs. ADCs represent a combination of chemotherapy and immunotherapy, more innovative chemotherapy. We emphasize the intricate interplay between tumor biology and therapeutic intervention, uncovering the mechanisms underlying ADC efficacy and the hurdles they must overcome. Each facet of ADC development is carefully examined, from the delicate balance between payload potency and safety to the quest for enhanced tumor penetration. We also elucidate the synergistic potential of combining ADCs with existing modalities, including chemotherapy and radiation therapy, to amplify therapeutic outcomes while mitigating adverse effects. As we navigate the complexities of solid tumor oncology, a profound understanding of the immunotherapeutic potential of ADCs is gained, offering hope for a cure for patients and clinicians alike. Henceforth, we delve into this transformative journey as we advance in solid tumor treatment regimens using immunotherapy with ADCs, poised at the forefront of oncological innovation.
Subjects
  • Antibody-drug conjuga...

  • Monoclonal antibody

  • Smart-chemotherapy

  • Solid tumor immunothe...

Copyright © 2016-2025  Indian Institute of Technology Jodhpur

Developed and maintained by Dr. Kamlesh Patel and Mr. C. Chhatwani, S. R. Ranganathan Learning Hub, IIT Jodhpur.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback